Fox19: 40 UC medical students to receive full-tuition scholarships thanks to $6.9M gift
New scholarship will honor two college alumni and will support Ohio-educated students
Forty total medical students at the University of Cincinnati College of Medicine will be the beneficiaries of the Webster-Gustin Medical Scholarship Fund thanks to one of the largest donations in the college’s history.
A $6.9 million gift made in honor of Warren Webster, MD, and Byron Gustin, MD, was able to create this scholarship that will help 10 students per incoming class over the next four years.
“Dr. Webster and Dr. Gustin are outstanding physicians who have remained here in Cincinnati for their education, training and career. They are incredible role models for our students. We are honored and proud to have this scholarship recognize them,” said Andrew T. Filak Jr., MD, senior vice president for health affairs and Christian R. Holmes Professor and Dean.
Watch interviews with Dean Filak and first-year student Michael Brooks.
Featured image at top: Dean Andrew Filak Jr., MD Photo/UC Creative + Brand
Related Stories
Fall grads celebrate their success at commencement
December 12, 2025
The University of Cincinnati recognized more than 2,600 graduates at its fall commencement.
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.